Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist
- 1 October 1987
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 48 (4) , 560-564
- https://doi.org/10.1016/s0015-0282(16)59464-3
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Regression of uterine leiomyomas after treatment with gestrinone, an antiestrogen, antiprogesteroneAmerican Journal of Obstetrics and Gynecology, 1986
- Toward Removing Uterine Fibroids without Surgery: Subcutaneous Infusion of a Luteinizing Hormone-Releasing Hormone Agonist Commencing in the Luteal PhaseJournal of Clinical Endocrinology & Metabolism, 1986
- Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: A pilot studyAmerican Journal of Obstetrics and Gynecology, 1985
- Nasal Absorption of Nafarelin Acetate, the Decapeptide [D-Nal(2)6]LHRH, in Rhesus Monkeys IJournal of Pharmaceutical Sciences, 1984
- Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United StatesAmerican Journal of Obstetrics and Gynecology, 1982
- Tihe Concentrations of Progesterone, Estrone and Estradiol-17β in the Plasma of Pregnant RabbitsEndocrinology, 1973
- RAPID ENLARGEMENT OF A UTERINE FIBROID AFTER CLOMIPHENE THERAPYBJOG: An International Journal of Obstetrics and Gynaecology, 1973
- Endometrial changes associated with myomata of the uterusJournal of Clinical Pathology, 1970
- Precision and Accuracy of Bone Mineral Determination by Direct Photon AbsorptiometryInvestigative Radiology, 1968
- Radioimmunoassay for Human Follicle-Stimulating Hormone1Journal of Clinical Endocrinology & Metabolism, 1967